CIPO Patents = 1

EPO Patents = 2

Forward Citations = 0

Loading Chart...

7 inventors (with patents filed for the assignee):

Isabel Kalofonos (5 out of 6 patents)

William Martin-Doyle (5 out of 6 patents)

G Patrick Stahly (4 out of 19 patents)

4. Travis Lee Houston (4 out of 24 patents)

5. Dimitris Kalofonos (4 out of 12 patents)

6. Jeffrey S Stults (4 out of 35 patents)

7. Judy Caron (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 10464912 - Choline cocrystal of epalrestat (2019-11-05),

2. 9611234 - Choline cocrystal of epalrestat (2017-04-04),

3. 9566269 - Modified release compositions of epalrestat or a derivative thereof and methods for using the same (2017-02-14),

4. 9447056 - Solid forms of epalrestat (2016-09-20),

5. 8697735 - Solid forms of epalrestat (2014-04-15),

Bionevia Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to discovering and developing innovative therapies for various diseases. With a focus on research and development, Bionevia is committed to improving the lives of patients through novel treatments and advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#335 in Cambridge, MA

#2,814 in Massachusetts

#50,233 in US

Cambridge, MA, United States of America

Bionevia Pharmaceuticals, Inc.

Forward Citations = 0

7 inventors:

Isabel Kalofonos (5 out of 6 patents)

William Martin-Doyle (5 out of 6 patents)

G Patrick Stahly (4 out of 19 patents)

4. Travis Lee Houston (4 out of 24 patents)

5. Dimitris Kalofonos (4 out of 12 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com